Blood glucose levels can be a reliable indicator of diabetes risk. But in some populations, it's not enough to catch the ...

Microsoft announced a new extension pack for Visual Studio Code that bundles tools for Python development, assisted by the AI-powered GitHub Copilot and a data wrangler. The new Python Data Science ...

MoonPay’s new Dawn CLI AI trading product lets users turn plain-English prompts into automated crypto trading strategies.

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

Forbes contributors publish independent expert analyses and insights. Daryl Austin is a Utah-based reporter who covers health and wellness. For decades, continuous glucose monitors (CGMs) were ...

Edward Kang’s RetinaMind analyzes patients’ retinal images and accurately diagnoses neurodevelopmental disorders 89 percent ...

In people with Type 1 diabetes (T1D), the immune system shuts down the body's ability to make the hormone insulin, ...

If you’re on insulin to treat type 1 or type 2 diabetes, it’s critical to know exactly how to use it. “Insulin can be a very dangerous drug if used improperly,” says Stanley Mathew, MD, an ...

Three-quarters of new code at Google is being generated by AI, the company said. The number has been steadily increasing as the company pushes staff to adopt AI tools. Google CEO Sundar Pichai said a ...

OBSCORE is a data-driven tool that identifies high-risk individuals for obesity-related diseases, enhancing treatment ...

LAS VEGAS — Off-label use of GLP-1 drugs by people with type 1 diabetes (T1D) did not lead to diabetic ketoacidosis (DKA) or pancreatitis in a large 1-year single-center study. Moreover, GLP-1 agonist ...